OR WAIT null SECS
May 09, 2024
Tara Dougal, content director, Pharma, Informa Markets, discusses successes and insights from this year’s CPHI North America and the agenda for the upcoming CPHI Milan.
Purna Thakker, founder and CEO of ADPT Solution, discusses common issues that companies face with FDA regulations at CPHI North America.
The company’s presentation at ASGCT includes preliminary data results for a child who received the gene therapy.
May 08, 2024
Experiments conducted by the downstream technology team at Spark Therapeutics involving metal ion-containing additives showed improved capsid clearance in AAV production.
The company is presenting preclinical data at the American Society of Gene & Cell Therapy annual meeting that supports the potential of the company’s CAP-002 gene therapy for correcting neurological phenotypes associated with genetic epilepsy due to syntaxin-binding protein 1 (STXBP1) mutations.
May 07, 2024
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.
The two companies will combine their cell therapy platforms to develop convertibleCAR programs targeting solid tumors.
May 06, 2024
The request for more information was received weeks after an application to the FTC was refiled to approve the deal.
May 04, 2024
A new draft guidance issued by FDA covers human- and animal-derived materials used in the manufacture of advanced therapy medicinal products.
May 03, 2024
Cormica’s first US Acquisition is intended to support to organic growth of TPM laboratories.